In this review we highlight recent progress in the study of Rheb family GTPases. Structural studies using X-ray crystallography and NMR have given us insight into unique features of this GTPase. Combined with mutagenesis studies, these works have expanded our understanding of residues that affect Rheb GTP/GDP bound ratios, effector protein interactions, and stimulation of mTORC1 signaling. Analysis of cancer genome databases has revealed that several human carcinomas contain activating mutations of the protein. Rheb's role in activating mTORC1 signaling at the lysosome in response to stimuli has been further elucidated. Rheb has also been suggested to play roles in other cellular pathways including mitophagy and peroxisomal ROS response. A ...
The small GTPase Rheb displays unique biological and biochemical properties different from other sma...
During the past 20 years, GTP-binding proteins of the Rho family have been identified as essential p...
Mutations in the TSC1 or TSC2 genes cause tuberous sclerosis, a benign tumour syndrome in humans(1,2...
Ras homolog enriched in brain (RHEB) is a member of the Ras superfamily of small GTPases that are re...
The activator of mammalian target of rapamycin complex 1 (mTORC1), Ras homolog enriched in brain (Rh...
The research described in this thesis can be divided in three major parts. First we address the ques...
AbstractThe small G protein Rheb (Ras homologue enriched in brain) is known to promote mammalian tar...
The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in human cancer a...
The insulin-signaling pathway controls different aspects of cell proliferation, survival, growth and...
SummaryRheb, an activator of mammalian target of rapamycin (mTOR), displays low intrinsic GTPase act...
One of the main research areas in biology from the mid‐1980s through the 1990s was the elucidation o...
BackgroundRHEB is a unique member of the RAS superfamily of small GTPases expressed in all tissues a...
The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in human cancer a...
The small GTPase Rheb has been found to be overexpressed in some tumors, and its overexpression is t...
AbstractThe small G-protein Rheb regulates cell growth via the mTORC1 complex by incompletely unders...
The small GTPase Rheb displays unique biological and biochemical properties different from other sma...
During the past 20 years, GTP-binding proteins of the Rho family have been identified as essential p...
Mutations in the TSC1 or TSC2 genes cause tuberous sclerosis, a benign tumour syndrome in humans(1,2...
Ras homolog enriched in brain (RHEB) is a member of the Ras superfamily of small GTPases that are re...
The activator of mammalian target of rapamycin complex 1 (mTORC1), Ras homolog enriched in brain (Rh...
The research described in this thesis can be divided in three major parts. First we address the ques...
AbstractThe small G protein Rheb (Ras homologue enriched in brain) is known to promote mammalian tar...
The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in human cancer a...
The insulin-signaling pathway controls different aspects of cell proliferation, survival, growth and...
SummaryRheb, an activator of mammalian target of rapamycin (mTOR), displays low intrinsic GTPase act...
One of the main research areas in biology from the mid‐1980s through the 1990s was the elucidation o...
BackgroundRHEB is a unique member of the RAS superfamily of small GTPases expressed in all tissues a...
The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in human cancer a...
The small GTPase Rheb has been found to be overexpressed in some tumors, and its overexpression is t...
AbstractThe small G-protein Rheb regulates cell growth via the mTORC1 complex by incompletely unders...
The small GTPase Rheb displays unique biological and biochemical properties different from other sma...
During the past 20 years, GTP-binding proteins of the Rho family have been identified as essential p...
Mutations in the TSC1 or TSC2 genes cause tuberous sclerosis, a benign tumour syndrome in humans(1,2...